Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Fair enough, glad you believe we could potentially see a $50 stock price (which is approximately a $2 billion valuation). I am realistic to recognize that when O'Connor has made comparisons that off all goes well ADXS could be valued on par with Imclone which was sold for over $6 billion that is just hogwash and a convenient reference because he worked there before it was sold (and he actually left around a year or thereabouts before it was sold so wasn't even involved in the sale). If we get taken our for a couple billion I think we will all be very happy. Highly unlikely ADXS would fetch anything higher than that becuase given we arrived already in Phase 3 we would be valued higher today if we were on the path to a several billion dollar valuation.